NMRA · Neumora Therapeutics, Inc.
$1.60
-0.13 (-7.51%)
At close · Aug 14
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“the current available cash and cash equivalents will not be sufficient to fund the Company’s operating plans for at least twelve months from the issuance date of these condensed consolidated financial statements. Accordingly, the Company has concluded that substantial doubt exists about its ability to continue as a going concern.”View the 10-Q filed Aug 14, 2026
Market Cap
$300.63M
Shares
187.90M
Registered funds — mutual funds, ETFs and closed-end funds — whose latest Form N-PORT portfolio report holds this stock, matched by the stock's CUSIP. Each row is one fund position with its size, value and weight in that fund.
Funds holding NMRA
44 fund positions| Fund | Ticker | Balance | Value | % of Fund | Side | Reported | Open |
|---|---|---|---|---|---|---|---|
| VANGUARD TOTAL STOCK MARKET INDEX FUND | — | 2,796,154 | $5,452,500 | 0.00% | Long | 2026-03-31 | |
| VANGUARD EXTENDED MARKET INDEX FUND | — | 1,001,813 | $1,953,535 | 0.00% | Long | 2026-03-31 | |
| Fidelity Extended Market Index Fund | — | 465,376 | $860,946 | 0.00% | Long | 2026-05-31 | |
| iShares Biotechnology ETF | — | 421,430 | $821,789 | 0.01% | Long | 2026-03-31 | |
| Federated Hermes MDT Small Cap Growth Fund | — | 314,119 | $775,874 | 0.10% | Long | 2026-04-30 | |
| Schwab U.S. Small-Cap ETF | — | 415,640 | $768,934 | 0.00% | Long | 2026-05-31 | |
| Dimensional U.S. Small Cap ETF | — | 221,105 | $546,129 | 0.00% | Long | 2026-04-30 | |
| Invesco RAFI US 1500 Small-Mid ETF | — | 196,001 | $484,122 | 0.02% | Long | 2026-04-30 | |
| Franklin Biotechnology Discovery Fund | — | 186,984 | $461,850 | 0.04% | Long | 2026-04-30 | |
| Ultra-Small Company Market Fund | — | 225,000 | $438,750 | 0.36% | Long | 2026-03-31 | |
| VANGUARD HEALTH CARE INDEX FUND | — | 179,998 | $332,996 | 0.00% | Long | 2026-05-31 | |
| Fidelity Total Market Index Fund | — | 173,358 | $320,712 | 0.00% | Long | 2026-05-31 | |
| Fidelity Series Total Market Index Fund | — | 136,857 | $253,185 | 0.00% | Long | 2026-05-31 | |
| BlackRock Advantage Small Cap Growth Fund | — | 117,013 | $228,175 | 0.03% | Long | 2026-03-31 | |
| Fidelity Nasdaq Composite Index Fund | — | 99,428 | $183,942 | 0.00% | Long | 2026-05-31 | |
| U.S. SMALL CAP PORTFOLIO | — | 62,855 | $155,252 | 0.00% | Long | 2026-04-30 | |
| LVIP State Street Small-Cap Index Fund | — | 78,100 | $132,770 | 0.01% | Long | 2026-06-30 | |
| Fidelity ZERO Total Market Index Fund | — | 46,192 | $114,094 | 0.00% | Long | 2026-04-30 | |
| Schwab Total Stock Market Index Fund | — | 42,000 | $103,740 | 0.00% | Long | 2026-04-30 | |
| VANGUARD INSTITUTIONAL TOTAL STOCK MARKET INDEX FUND | — | 51,935 | $101,273 | 0.00% | Long | 2026-03-31 | |
| Schwab U.S. Broad Market ETF | — | 50,919 | $94,200 | 0.00% | Long | 2026-05-31 | |
| VANGUARD BALANCED INDEX FUND | — | 41,991 | $81,882 | 0.00% | Long | 2026-03-31 | |
| Fidelity ZERO Extended Market Index Fund | — | 31,178 | $77,010 | 0.00% | Long | 2026-04-30 | |
| Principal Healthcare Innovators ETF | BCHP | 5,771 | $56,729 | 0.35% | Long | 2024-06-30 | |
| Small-Cap Index Portfolio | — | 29,248 | $49,722 | 0.01% | Long | 2026-06-30 | |
| Avantis U.S. Small Cap Equity ETF | — | 25,189 | $46,600 | 0.00% | Long | 2026-05-31 | |
| Blackstone Alternative Multi-Strategy Fund | — | 18,401 | $35,882 | 0.00% | Long | 2026-03-31 | |
| Fidelity Flex Small Cap Index Fund | — | 13,496 | $33,335 | 0.01% | Long | 2026-04-30 | |
| U.S. MICRO CAP PORTFOLIO | — | 12,704 | $31,379 | 0.00% | Long | 2026-04-30 | |
| Small-Mid Cap Equity Fund | MSLC | 3,105 | $30,864 | 0.01% | Long | 2024-11-30 | |
| Dimensional U.S. Core Equity 2 ETF | — | 12,147 | $30,003 | 0.00% | Long | 2026-04-30 | |
| U.S. CORE EQUITY 1 PORTFOLIO | — | 7,610 | $18,797 | 0.00% | Long | 2026-04-30 | |
| Invesco Nasdaq Biotechnology ETF | — | 8,812 | $16,302 | 0.02% | Long | 2026-05-31 | |
| Victory Extended Market Index Fund | — | 6,372 | $15,739 | 0.00% | Long | 2026-04-30 | |
| PD Small-Cap Growth Index Portfolio | — | 9,190 | $15,623 | 0.01% | Long | 2026-06-30 | |
| JNL/DFA U.S. Small Cap Fund | — | 8,006 | $15,612 | 0.00% | Long | 2026-03-31 | |
| Dimensional US Core Equity 1 ETF | — | 5,256 | $12,982 | 0.00% | Long | 2026-04-30 | |
| ProShares Ultra Nasdaq Biotechnology | — | 6,176 | $11,426 | 0.02% | Long | 2026-05-31 | |
| Avantis U.S. Small Cap Equity Fund | — | 4,145 | $7,668 | 0.01% | Long | 2026-05-31 | |
| iShares Neuroscience and Healthcare ETF | — | 3,060 | $7,558 | 0.15% | Long | 2026-04-30 | |
| Goldman Sachs Absolute Return Tracker Fund | — | 3,032 | $5,912 | 0.00% | Long | 2026-03-31 | |
| Total Stock Market Index Trust | — | 2,957 | $5,766 | 0.00% | Long | 2026-03-31 | |
| Avantis Total Equity Markets ETF | — | 1,022 | $1,891 | 0.00% | Long | 2026-05-31 | |
| Knights of Columbus U.S. ALL CAP INDEX FUND | — | 481 | $1,188 | 0.00% | Long | 2026-04-30 |
Showing 1–44 of 44 positions
Key facts
CIK
1885522
CUSIP
640979100
13F (30d)
114 filings
112 filers
Visit website
Investor relations